Cargando…

A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine

The murine intestinal nematode Heligmosomoides polygyrus releases the H. polygyrus Alarmin Release Inhibitor (HpARI) - a protein which binds to IL-33 and to DNA, effectively tethering the cytokine in the nucleus of necrotic cells. Previous work showed that a non-natural truncation consisting of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauché, Caroline, Vacca, Francesco, Chia, Shin Li, Richards, Josh, Gregory, William F., Ogunkanbi, Adefunke, Wear, Martin, McSorley, Henry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338556/
https://www.ncbi.nlm.nih.gov/pubmed/32695116
http://dx.doi.org/10.3389/fimmu.2020.01363
_version_ 1783554705328177152
author Chauché, Caroline
Vacca, Francesco
Chia, Shin Li
Richards, Josh
Gregory, William F.
Ogunkanbi, Adefunke
Wear, Martin
McSorley, Henry J.
author_facet Chauché, Caroline
Vacca, Francesco
Chia, Shin Li
Richards, Josh
Gregory, William F.
Ogunkanbi, Adefunke
Wear, Martin
McSorley, Henry J.
author_sort Chauché, Caroline
collection PubMed
description The murine intestinal nematode Heligmosomoides polygyrus releases the H. polygyrus Alarmin Release Inhibitor (HpARI) - a protein which binds to IL-33 and to DNA, effectively tethering the cytokine in the nucleus of necrotic cells. Previous work showed that a non-natural truncation consisting of the first 2 domains of HpARI (HpARI_CCP1/2) retains binding to both DNA and IL-33, and inhibited IL-33 release in vivo. Here, we show that the affinity of HpARI_CCP1/2 for IL-33 is significantly lower than that of the full-length protein, and that HpARI_CCP1/2 lacks the ability to prevent interaction of IL-33 with its receptor. When HpARI_CCP1/2 was applied in vivo it potently amplified IL-33-dependent immune responses to Alternaria alternata allergen, Nippostrongylus brasiliensis infection and recombinant IL-33 injection, in direct contrast to the IL-33-suppressive effects of full-length HpARI. Mechanistically, we found that HpARI_CCP1/2 is able to bind to and stabilize IL-33, preventing its degradation and maintaining the cytokine in its active form. This study highlights the importance of IL-33 inactivation, the potential for IL-33 stabilization in vivo, and describes a new tool for IL-33 research.
format Online
Article
Text
id pubmed-7338556
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73385562020-07-20 A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine Chauché, Caroline Vacca, Francesco Chia, Shin Li Richards, Josh Gregory, William F. Ogunkanbi, Adefunke Wear, Martin McSorley, Henry J. Front Immunol Immunology The murine intestinal nematode Heligmosomoides polygyrus releases the H. polygyrus Alarmin Release Inhibitor (HpARI) - a protein which binds to IL-33 and to DNA, effectively tethering the cytokine in the nucleus of necrotic cells. Previous work showed that a non-natural truncation consisting of the first 2 domains of HpARI (HpARI_CCP1/2) retains binding to both DNA and IL-33, and inhibited IL-33 release in vivo. Here, we show that the affinity of HpARI_CCP1/2 for IL-33 is significantly lower than that of the full-length protein, and that HpARI_CCP1/2 lacks the ability to prevent interaction of IL-33 with its receptor. When HpARI_CCP1/2 was applied in vivo it potently amplified IL-33-dependent immune responses to Alternaria alternata allergen, Nippostrongylus brasiliensis infection and recombinant IL-33 injection, in direct contrast to the IL-33-suppressive effects of full-length HpARI. Mechanistically, we found that HpARI_CCP1/2 is able to bind to and stabilize IL-33, preventing its degradation and maintaining the cytokine in its active form. This study highlights the importance of IL-33 inactivation, the potential for IL-33 stabilization in vivo, and describes a new tool for IL-33 research. Frontiers Media S.A. 2020-06-30 /pmc/articles/PMC7338556/ /pubmed/32695116 http://dx.doi.org/10.3389/fimmu.2020.01363 Text en Copyright © 2020 Chauché, Vacca, Chia, Richards, Gregory, Ogunkanbi, Wear and McSorley. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Chauché, Caroline
Vacca, Francesco
Chia, Shin Li
Richards, Josh
Gregory, William F.
Ogunkanbi, Adefunke
Wear, Martin
McSorley, Henry J.
A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
title A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
title_full A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
title_fullStr A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
title_full_unstemmed A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
title_short A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
title_sort truncated form of hpari stabilizes il-33, amplifying responses to the cytokine
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338556/
https://www.ncbi.nlm.nih.gov/pubmed/32695116
http://dx.doi.org/10.3389/fimmu.2020.01363
work_keys_str_mv AT chauchecaroline atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT vaccafrancesco atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT chiashinli atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT richardsjosh atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT gregorywilliamf atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT ogunkanbiadefunke atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT wearmartin atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT mcsorleyhenryj atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT chauchecaroline truncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT vaccafrancesco truncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT chiashinli truncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT richardsjosh truncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT gregorywilliamf truncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT ogunkanbiadefunke truncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT wearmartin truncatedformofhparistabilizesil33amplifyingresponsestothecytokine
AT mcsorleyhenryj truncatedformofhparistabilizesil33amplifyingresponsestothecytokine